BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Policy

  Daiichi Sankyo, Inc., Apotex Corp. Settle Evoxac Litigation

  August 5, 2010

   · 

  1 min read
• FDA

  FDA Approves Sanofi-Aventis (France)'s New Taxotere(R) (docetaxel) Injection Concentrate Formulation

  August 5, 2010

   · 

  10 min read
• Genetown

  Cytel Inc. Announces Compass(R) - The Only Professional Adaptive Trial Software Package for Bayesian or Frequentist Dose-Finding Studies

  August 5, 2010

   · 

  2 min read
• Drug Development

  Data from Dyax Corp.'s First Phase 3 Trial (EDEMA3(R)) for KALBITOR(R) (ecallantide) Published in The New England Journal of Medicine

  August 5, 2010

   · 

  7 min read
• Business

  Insmed Incorporated Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2010

  August 5, 2010

   · 

  7 min read
• Business

  Cardica, Inc. to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010

  August 5, 2010

   · 

  1 min read
• Biotech Bay

  NewCardio Completes First Revenue-Generating Study Using QTinno

  August 5, 2010

   · 

  4 min read
• Business

  Ceapro Inc. Reports 2010 Second Quarter Financial and Operating Results

  August 5, 2010

   · 

  8 min read
• Pharm Country

  Sagent Pharmaceuticals, Inc.’ Sales Team Gets the Edge in the Marketplace

  August 5, 2010

   · 

  2 min read
• Business

  US Oncology, Inc. Reports Second Quarter 2010 Operating Results

  August 5, 2010

   · 

  16 min read